INOZYME PHARMA INC. -
5.2400
08-10月-24 12:08:48
15 分の遅延
株式
+0.0200
+0.38%
本日の幅
5.2400 - 5.4552
ISIN
N/A
ソース
NASDAQ
-
09 6 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Q1 2021 Financial Results and Provides Business Highlights
12 5 2021 06:00:00 提供 Nasdaq GlobeNewswire
-
07 5 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Inozyme Pharma to Present at the BofA Securities 2021 Virtual Healthcare Conference
06 5 2021 07:30:01 提供 Nasdaq GlobeNewswire
-
Inozyme Pharma Publishes Data Supporting INZ-701 as a Potential Treatment for ENPP1 Deficiency
29 4 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Inozyme Pharma to Present Burden of Illness Data at the 2021 ACMG Annual Clinical Genetics Meeting
08 4 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Inozyme Pharma Expands its Scientific Advisory Board
01 4 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Full Year 2020 Financial Results and Provides Business Highlights
25 3 2021 06:00:00 提供 Nasdaq GlobeNewswire
-
The Balancing Act® on Lifetime to Feature ENPP1 Deficiency
11 3 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Inozyme Pharma Appoints Deborah Wenkert, M.D., as Senior Vice President and Chief Medical Officer
04 2 2021 06:00:00 提供 Nasdaq GlobeNewswire
-
04 1 2021 06:00:00 提供 Nasdaq GlobeNewswire